[144] IBEX Ltd SEC Filing

Rhea-AI Filing Summary

The filer submitted a Form 144 for IBEX Ltd showing a proposed sale of 1,275 common shares to be executed via NASDAQ with an aggregate market value of $50,466.87 and an approximate sale date of 10/02/2025. The shares were acquired on 09/30/2025 by the vesting of a performance grant totaling 4,196 shares. The filing records prior sales by the same person of 438 shares for $12,732.51 on 08/26/2025 and 2,295 shares for $93,475.69 on 09/19/2025. The notice identifies the broker as Global Shares Financial Services Inc. and reports total shares outstanding of 13,315,077. The signer certifies no undisclosed material adverse information.

Positive

• Form 144 filed specifying broker (Global Shares Financial Services Inc.) and exchange (NASDAQ)
• Proposed sale ties to a vested performance grant (acquired 09/30/2025), indicating authorized internal compensation realization

Negative

• None.

Insights

Insider Transactions Analyst

Insider plans to sell vested shares totaling 1,275 on NASDAQ for about $50,467.

This Form 144 reports a proposed sale on 10/02/2025 of 1,275 common shares acquired via a performance grant vesting on 09/30/2025. The filing names Global Shares Financial Services Inc. as the broker and lists 13,315,077 shares outstanding, providing context for the size of the proposed sale relative to the company's share count.

The filing also discloses two recent insider sales: 438 shares for $12,732.51 on 08/26/2025 and 2,295 shares for $93,475.69 on 09/19/2025, showing ongoing disposition activity by the same person.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	GLOBAL SHARES FINANCIAL SERVICES INC. 575 WASHINGTON BLVD FLOOR 9 JERSEY CITY NJ 07310-1616	1275	50466.87	13315077	10/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	09/30/2025	VESTING OF PERFORMANCE GRANT	ISSUER			4196	09/30/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
TAYLOR C GREENWALD c/o IBEX LIMITED 1717 Pennsylvania Avenue NW, Suite 825 Washington DC 20006	COMMON	08/26/2025	438	12732.51
TAYLOR C. GREENWALD c/o IBEX LIMITED 1717 Pennsylvania Avenue NW, Suite 825 Washington DC 20006	COMMON	09/19/2025	2295	93475.69

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the IBEX (IBEX) Form 144 disclose about the proposed sale?

The Form 144 discloses a proposed sale of 1,275 common shares on 10/02/2025 with an aggregate market value of $50,466.87 via NASDAQ.

How were the shares being sold by the IBEX insider acquired?

The shares were acquired through the vesting of a performance grant on 09/30/2025, totaling 4,196 vested shares.

What prior insider sales does the Form 144 report for this person?

The filing reports sales of 438 shares for $12,732.51 on 08/26/2025 and 2,295 shares for $93,475.69 on 09/19/2025.

Who is the broker handling the proposed IBEX share sale?

The broker listed on the Form 144 is Global Shares Financial Services Inc. located at the address provided in the filing.

How large is the proposed sale relative to IBEX's outstanding shares?

The proposed sale of 1,275 shares is against a reported 13,315,077 shares outstanding in the filing.